Program genetic anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Tumor Cells, Cultured Cell Line HCT116 Cells HT29 Cells MCF-7 Cells HeLa Cells K562 Cells HL-60 Cells Hep G2 Cells Cells, Cultured Mitochondria

Organisms5

Mice, Nude Mice, Inbred BALB C Taxus Mice, Inbred C57BL Mice, SCID

Diseases22

Radiation Injuries Neoplasms Radiation Injuries, Experimental Radiation Pneumonitis Neoplasms, Radiation-Induced Breast Neoplasms Acute Radiation Syndrome Colonic Neoplasms Neoplasms, Experimental Brain Neoplasms Adenocarcinoma Radiodermatitis Lung Neoplasms Leukemia P388 Head and Neck Neoplasms Carcinoma, Squamous Cell Leukemia, Radiation-Induced Glioblastoma Glioma Melanoma Abnormalities, Radiation-Induced Ovarian Neoplasms

Chemicals and Drugs79

Antineoplastic Agents Doxorubicin Antineoplastic Agents, Phytogenic Cisplatin Antibiotics, Antineoplastic Drug Carriers Radiation-Sensitizing Agents Ellipticines Etoposide Paclitaxel Camptothecin P-Glycoprotein Radiation-Protective Agents DNA Topoisomerases, Type II Enzyme Inhibitors Prodrugs Fluorouracil DNA Topoisomerase I Inhibitors Tumor Suppressor Protein p53 Daunorubicin Plant Extracts Platinum Caspases Antimetabolites, Antineoplastic Nanocapsules Proto-Oncogene Proteins c-bcl-2 Caspase 3 Cobalt Radioisotopes Organoplatinum Compounds Antineoplastic Agents, Alkylating Drugs, Investigational Neoplasm Proteins Mitoxantrone Mitomycin DNA Adducts Intercalating Agents Multidrug Resistance-Associated Proteins Bleomycin DNA-Binding Proteins Xanthones Topoisomerase II Inhibitors Topoisomerase Inhibitors RNA, Messenger Vinblastine ATP-Binding Cassette Transporters RNA, Small Interfering Adjuvants, Pharmaceutic DNA Topoisomerases, Type I Razoxane Tubulin Modulators Coordination Complexes Anticarcinogenic Agents Reactive Oxygen Species Vincristine Liposomes Triazines Protein-Serine-Threonine Kinases Teniposide Histone Deacetylase Inhibitors Angiogenesis Inhibitors Cesium Radioisotopes DNA, Neoplasm Pyrazines Nimustine Protein Kinase Inhibitors Topotecan Deoxycytidine Cell Cycle Proteins Poly(ADP-ribose) Polymerases Chlorambucil Indoles Vinca Alkaloids Boronic Acids Triterpenes Depsipeptides Benzoquinones Taxoids Polyethylene Glycols

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Radiation Dosage Program Evaluation Dose-Response Relationship, Radiation Drug Screening Assays, Antitumor Radiation Monitoring Drug Delivery Systems Radiation Injuries, Experimental Drug Carriers Xenograft Model Antitumor Assays Radiotherapy Combined Modality Therapy Radiometry Radiotherapy Dosage Inhibitory Concentration 50 Drug Design Treatment Outcome Drug Evaluation, Preclinical Drug Discovery Models, Biological Antineoplastic Combined Chemotherapy Protocols Neoplasms, Experimental Nanocapsules Neoplasm Transplantation Radiotherapy, Conformal Radiation Hybrid Mapping Molecular Targeted Therapy Flow Cytometry Blotting, Western Clinical Trials as Topic Dose Fractionation Transplantation, Heterologous Brachytherapy Radiotherapy, Intensity-Modulated Tumor Burden Questionnaires Radiotherapy Planning, Computer-Assisted Clinical Trials, Phase I as Topic Retrospective Studies Follow-Up Studies Radiotherapy, Adjuvant Pilot Projects Models, Molecular Transfection Body Burden Mass Screening Tumor Stem Cell Assay Synchrotrons Gene Expression Profiling Reproducibility of Results Risk Factors Technology, Radiologic Fluoroscopy Particle Accelerators Phytotherapy Reverse Transcriptase Polymerase Chain Reaction Thermoluminescent Dosimetry Exercise Therapy Whole-Body Irradiation Feasibility Studies Tomography, X-Ray Computed Radiography Drug Approval

Psychiatry and Psychology1

Health Knowledge, Attitudes, Practice

Phenomena and Processes50

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Apoptosis Drug Resistance, Neoplasm Cell Survival Cosmic Radiation Gamma Rays DNA Damage Cell Proliferation Background Radiation Time Factors Ultraviolet Rays Drug Resistance, Multiple Inhibitory Concentration 50 Dose-Response Relationship, Drug Molecular Structure Cell Cycle Radiation Effects Drug Synergism DNA Repair Gene Expression Regulation, Neoplastic Signal Transduction X-Rays Cell Division Cell Death DNA Adducts Structure-Activity Relationship Drug Resistance Base Sequence Linear Energy Transfer Mutation Genes, MDR Cell Cycle Checkpoints Down-Regulation Transfection Algorithms G2 Phase Particle Size Phosphorylation Radiation, Nonionizing Enzyme Activation Electromagnetic Radiation Sunlight Tissue Distribution Protein Binding DNA Fragmentation Up-Regulation

Disciplines and Occupations8

Radiation Oncology Drug Design Nanomedicine Drug Discovery Radiobiology Radiation Genetics Pharmacogenetics Technology, Radiologic

Anthropology, Education, Sociology and Social Phenomena9

Government Programs Health Education Curriculum Internship and Residency Nuclear Warfare National Cancer Institute (U.S.)National Institutes of Health (U.S.)Patient Education as Topic Drug Approval

Technology, Industry, Agriculture7

Nanoparticles Nanomedicine Nanocapsules Liposomes Nanostructures Technology, Radiologic Polyethylene Glycols

Information Science8

Radiotherapy, Conformal Software Molecular Sequence Data Base Sequence Radiotherapy, Intensity-Modulated Questionnaires Radiotherapy Planning, Computer-Assisted Algorithms

Health Care42

Radiation Dosage Radiation Injuries Program Evaluation Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Program Development Cosmic Radiation Radiation Injuries, Experimental Ultraviolet Rays Radiation Effects Treatment Outcome National Health Programs Acute Radiation Syndrome Health Promotion Radioactive Hazard Release Managed Care Programs Health Education Clinical Trials as Topic Immunization Programs Questionnaires Clinical Trials, Phase I as Topic Retrospective Studies Follow-Up Studies Pilot Projects Body Burden Radiation Genetics Mass Screening Community Health Services National Cancer Institute (U.S.)Reproducibility of Results Relative Biological Effectiveness Risk Factors National Institutes of Health (U.S.)Sunlight Abnormalities, Radiation-Induced Thermoluminescent Dosimetry Patient Education as Topic Cost-Benefit Analysis Feasibility Studies Health Knowledge, Attitudes, Practice School Health Services

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care Geographicals

Antineoplastic Agents Radiation Dosage Radiation, Ionizing Radiation Injuries Program Evaluation Dose-Response Relationship, Radiation Radiation Tolerance Radiation Drug Screening Assays, Antitumor Cell Line, Tumor Radiation Protection Radiation Monitoring Neoplasms Program Development Doxorubicin Apoptosis Drug Resistance, Neoplasm Radiation Oncology Cell Survival Antineoplastic Agents, Phytogenic Cisplatin Antibiotics, Antineoplastic Drug Delivery Systems Cosmic Radiation Gamma Rays Radiation Injuries, Experimental Tumor Cells, Cultured DNA Damage Radiation Pneumonitis Drug Carriers Xenograft Model Antitumor Assays Mice, Nude Neoplasms, Radiation-Induced Radiation-Sensitizing Agents Radiotherapy Cell Proliferation Government Programs Background Radiation Ellipticines Time Factors Combined Modality Therapy Ultraviolet Rays Etoposide United States Radiometry Paclitaxel Camptothecin Breast Neoplasms Radiotherapy Dosage Drug Resistance, Multiple Inhibitory Concentration 50 Dose-Response Relationship, Drug Molecular Structure P-Glycoprotein Cell Cycle Radiation Effects Drug Design Treatment Outcome Drug Synergism Radiation-Protective Agents National Health Programs DNA Topoisomerases, Type II Enzyme Inhibitors Prodrugs DNA Repair Gene Expression Regulation, Neoplastic Fluorouracil Drug Evaluation, Preclinical DNA Acute Radiation Syndrome Topoisomerase I Inhibitors Signal Transduction Tumor Suppressor Protein p53 Daunorubicin Nanoparticles Nanomedicine Drug Discovery Plant Extracts Health Promotion Models, Biological Colonic Neoplasms Platinum Caspases X-Rays Radioactive Hazard Release Antimetabolites, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Neoplasms, Experimental Nanocapsules Neoplasm Transplantation Radiobiology Cell Division Proto-Oncogene Proteins c-bcl-2 Caspase 3 Radiotherapy, Conformal Cobalt Radioisotopes Organoplatinum Compounds Radiation Hybrid Mapping Cell Death Molecular Targeted Therapy

No FAQ available that match "program genetic anticancer drugs or radiation"